| EMA number | EMEA/H/C/002777 |
| ATC code | J05AE14 |
| Authorisation | 14 May 2014 |
| Withdrawn | 1 May 2018 |
| Revision | 13 |
Olysio is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adult patients. For hepatitis C virus (HCV) genotype specific activity.